Iroko is dedicated to advancing the science of analgesia. Iroko Pharmaceuticals is named for the majestic West African iroko tree. Its deep roots represent strength and stability, while its leaves symbolize renewal and innovation. At Iroko, we believe it is possible to offer new options for responsible pain management. Medical and regulatory organizations have recommended the use of the lowest effective doses of NSAIDs for the shortest duration of time. We are using innovative proprietary SoluMatrix Fine Particle Technology™ to develop new drug products based on existing NSAIDs to relieve pain at lower doses. To learn more, please visit our Corporate Website.
Location: United States, Pennsylvania, Philadelphia
Employees: 51-200
Founded date: 2007
Investors 1
Mentions in press and media 6
| Date | Title | Description | Source |
| 12.06.2014 | Iroko takes low dose approach to osteoarthritis pain meds to... | Osteoarthritis is one of the most common causes of disability. It affects 27 million adults, accordi... | medcitynew... |
| 22.11.2013 | Iroko Pharmaceuticals Secures $75M in Debt Financing | PHILADELPHIA, PA, Global specialty pharmaceutical company dedicated to advancing the science of an... | vcnewsdail... |
| 21.11.2013 | Iroko Pharmaceuticals Closes $75M Debt Facility | Iroko Pharmaceuticals, LLC, a Philadelphia, PA-based global specialty pharmaceutical company dedicat... | finsmes.co... |
| 20.06.2013 | PTC Therapeutics joins the IPO scrum as more biotechs take a... | The nonsense mutation is the cause of Duchenne muscular dystrophy in about 13 percent of patients, o... | medcitynew... |
| - | PTC Therapeutics joins the IPO scrum as more biotechs take a... | It may not be the most complimentary assessment of a biotech’s initial public offering to say that i... | medcitynew... |
| - | Iroko takes low dose approach to osteoarthritis pain meds to... | Drug development companies have developed innovative approaches to drug formulation to avoid or redu... | medcitynew... |